Updated Mandatory Notices (-01412) - remove K. Canfield as counsel | Dec 11, 2018 | PAPER | PATENT OWNER |
Decision Motions to Seal | May 3, 2018 | PAPER | BOARD |
IPR2016-01412 Notice of Appeal | Mar 20, 2018 | PAPER | PATENT OWNER |
PATENT OWNERS¿¿¿ RENEWED MOTION TO SEAL | Feb 20, 2018 | PAPER | PATENT OWNER |
2086 Redacted Opioid-X Summit slides | Feb 20, 2018 | EXHIBIT | PATENT OWNER |
2087 Redacted Excerpts from Lab Notebook No. 394 | Feb 20, 2018 | EXHIBIT | PATENT OWNER |
2090 Redacted Excerpts from Lab Notebook No. 495 | Feb 20, 2018 | EXHIBIT | PATENT OWNER |
2102 Redacted Davidson Declaration with Exhibits A-C | Feb 20, 2018 | EXHIBIT | PATENT OWNER |
2088 Redacted Excerpts from Lab Notebook No. 503 | Feb 20, 2018 | EXHIBIT | PATENT OWNER |
2089 Redacted Excerpts from Lab Notebook No. 491 | Feb 20, 2018 | EXHIBIT | PATENT OWNER |
Final Written Decision | Feb 8, 2018 | PAPER | BOARD |
Hearing Transcript | Jan 23, 2018 | PAPER | BOARD |
Hearing Transcript | Jan 17, 2018 | PAPER | BOARD |
Petitioner's Updated Mandatory Notices Pursuant To 37 C.F.R. 42.8(a)(3) | Sep 27, 2017 | PAPER | PETITIONER |
Order - Oral Hearing | Sep 25, 2017 | PAPER | BOARD |
Reply to Patent Owners' Opposition to Petitioner's Motion to Exclude Evidence | Sep 11, 2017 | PAPER | PETITIONER |
Patent Owners' Opposition to Petitioner's Motion to Exclude Evidence | Sep 5, 2017 | PAPER | PATENT OWNER |
Petitioner's Responses to Patent Owners' Observations on Cross-Examination of Dr. Timko | Sep 5, 2017 | PAPER | PETITIONER |
Petitioner's Request for Oral Argument | Aug 21, 2017 | PAPER | PETITIONER |
Patent Owners' Request for Oral Hearing IPR2016-01412 | Aug 21, 2017 | PAPER | PATENT OWNER |
Patent Owners' Observations on Cross-Examination of Dr. Timko IPR2016-01412 | Aug 21, 2017 | PAPER | PATENT OWNER |
Patent Owners' Updated Exhibit List IPR2016-01412 | Aug 21, 2017 | PAPER | PATENT OWNER |
2109 Timko Deposition Transcript August 9, 2017 | Aug 21, 2017 | EXHIBIT | PATENT OWNER |
Petitioner's Motion to Exclude Evidence | Aug 21, 2017 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notices | Jul 31, 2017 | PAPER | PETITIONER |
Patent Owners' Notice of Deposition of Dr. Timko (-01412) | Jul 21, 2017 | PAPER | PATENT OWNER |
Pro Hac Motion_Normile - IPR2016-01412 | Jul 14, 2017 | PAPER | PATENT OWNER |
Patent Owners' Updated Mandatory Notice (-01412) | Jul 12, 2017 | PAPER | PATENT OWNER |
Patent Owners' Objections to Evidence Submitted by Petitioner Once Trial Has Been Instituted | Jul 7, 2017 | PAPER | PATENT OWNER |
Petitioner's Reply to Patent Owners' Response | Jun 29, 2017 | PAPER | PETITIONER |
Curriculum Vitae of Curriculum Vitae of Robert Joseph Timko, R.Ph., Ph.D. | Jun 29, 2017 | EXHIBIT | PETITIONER |
Patent Owners¿¿¿ Response in IPR2016-01028 | Jun 29, 2017 | EXHIBIT | PETITIONER |
Declaration of Dr. Robert Timko, Ph.D. | Jun 29, 2017 | EXHIBIT | PETITIONER |
Patent Owners¿¿¿ Response in IPR2016-01027 | Jun 29, 2017 | EXHIBIT | PETITIONER |
In re OxyContin Antitrust Litig., No. 04-md-1603 (S.D.N.Y. Jan. 14, 2014) Finding of Facts and Conclusion of Law | Jun 29, 2017 | EXHIBIT | PETITIONER |
Follonier et al. | Jun 29, 2017 | EXHIBIT | PETITIONER |
Serial No. 14/728,601, Nonfinal Rejection, Jan. 26, 2017 | Jun 29, 2017 | EXHIBIT | PETITIONER |
Serial No. 14/733,659, Nonfinal Rejection, Jan. 18, 2017 | Jun 29, 2017 | EXHIBIT | PETITIONER |
Serial No. 14/733,659, Final Rejection, June 8, 2017 | Jun 29, 2017 | EXHIBIT | PETITIONER |
F.E. Bailey, Jr. et al., High Molecular Weight Polymers of Ethylene Oxide | Jun 29, 2017 | EXHIBIT | PETITIONER |
Plaintiffs¿¿¿ Opening Claim Construction Brief in In re OxyContin Antitrust Litig. | Jun 29, 2017 | EXHIBIT | PETITIONER |
Summary of Alleged Diligence | Jun 29, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,948,437 | Jun 29, 2017 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2008/0287418 | Jun 29, 2017 | EXHIBIT | PETITIONER |
Serial No. 14/728,601, Final Rejection, June 9, 2017 | Jun 29, 2017 | EXHIBIT | PETITIONER |
Petitioner's Objections Under 37 C.F.R. 42.64 to Supplemental Evidence Served by Patent Owners | May 8, 2017 | PAPER | PETITIONER |
EXPUNGED | May 5, 2017 | PAPER | PETITIONER |
Petitioner's Objections Under 37 C.F.R. 42.64 To Evidence Served By Patent Owners Post Institution | Apr 17, 2017 | PAPER | PETITIONER |
Patent Owners' Motion to Seal Exhibits | Apr 10, 2017 | PAPER | PATENT OWNER |
Patent Owner's Response to Petition | Apr 10, 2017 | PAPER | PATENT OWNER |
2051 Palmieri Deposition IPR2016-01027_-01028 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2052 Oral Dosage Forms Resistant to Parenteral Abuse | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2056 Baker - Controlled Release of Biologically Active Agents (1987) | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2057 Kim - 84 J Pharm Sci 303 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2058 Alderman - 5 Int J Pharm Tech and Prod Mfr 1 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2064 McGinity - 4 Am Pharm Rev 25 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2066 Lapidus 55 J Pharm Sci 840 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2069 U.S. Patent No. 6177567 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2072 HPE 3rd ed TOC+Index | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2053 Palmieri Handwritten Calculation Notes | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2054 Byrn Supplemental Declaration with Appendices A-D | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2055 Frederichs - Opioids (2002) | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2059 Brookoff - 8 Jnl of General Internal Medicine 688 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2060 Downie - 7 Hospital Pharmacist 242 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2061 Crowley - 23 Biomaterials 4241 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2062 McGary - 46 J Polym Sci 51 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2063 Scheirs - 32 Polymer 2014 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2065 Mitchell 66 Intl J Pharm 233 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2067 Touitou 11 Intl J Pharm 131 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2068 FDA Guidance for Industry 1997 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2070 U.S. Patent No. 6067749 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2071 Poyhia - 8 Jnl of Pain and Symptom Mgmt 63 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2073 Approved Drug Prods. with Ther. Equiv. Evals. 2000 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2075 Zhang - 4 Pharm Dev Technol 241 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2089 HC Excerpts from Lab Notebook No. 491 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2090 HC Excerpts from Lab Notebook No. 495 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2092 Wright Declaration | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2096 US Application 60310514 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2074 Follonier - 20 Drug Dev Ind Pharm 1323 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2077 Deposition of Dr. Palmieri (March 21 2017) | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2078 10-30-14 FDA Development and Regulation of Abuse-Deterrent Opioid Medica | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2079 WO 9847535 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2080 Lin 19 Proceed Intern Symp Control Rel Bioact Mater 393 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2081 Oshlack Declaration | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2085 Sept. 2009 Purdue AdCom slides | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2086 HC Opioid-X Summit slides | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2087 HC Excerpts from Lab Notebook No. 394 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2088 HC Excerpts from Lab Notebook No. 503 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2091 HC Email from R. Paradiso attaching draft patent application | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2093 Severtson - 168 Drug and Alcohol Dep 219 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2094 Coplan - 100 Clin Pharm Therap 275 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2095 Paradiso Declaration | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2103 2016-11-09 Paper 13_Decision - Institution of Inter Partes Review | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2097 HC Tamper-Resistant Controlled Release Oxycodone Tablet examples | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2098 Email from R. Paradiso to P. Strassburger (June 1, 2001) | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2099 Email from P. Strassburger to R. Paradiso (June 18, 2001) | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2100 Email from R. Paradiso to P. Strassburger (June 18, 2001) | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2101 HC Draft patent application (July 2, 2001_docket number 200.1145) | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2102 HC Davidson Declaration with Exhibits A-C | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2104 U.S. Patent No. 8815287 | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
2105 Provisional Transmittal Letter_60310534 application | Apr 10, 2017 | EXHIBIT | PATENT OWNER |
Petitioner's Objections Under 37 C.F.R. 42.64 To Evidence Served By Patent Owners Post Institution | Mar 24, 2017 | PAPER | PETITIONER |
Palmieri Deposition Notice (-01412) | Mar 8, 2017 | PAPER | PATENT OWNER |
Patent Owners' Objections During Preliminary Proceeding | Mar 1, 2017 | PAPER | PATENT OWNER |
Petitioner's Objections During a Preliminary Proceeding | Mar 1, 2017 | PAPER | PETITIONER |
ADR Statement | Feb 21, 2017 | PAPER | PETITIONER |
Trial Instituted Document | Feb 14, 2017 | PAPER | BOARD |
Scheduling Order | Feb 14, 2017 | PAPER | BOARD |
Patent Owners' Preliminary Response IPR2016-01412 | Nov 18, 2016 | PAPER | PATENT OWNER |
2001 Byrn Declaration in Support of Preliminary Response IPR2016-01412 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2002 Oxy labeling 4-2013 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2004 2014-10-02 References considered | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2003 2014-08-14 IDS | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2011 UCM332288 (FDA opioid timeline) | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2013 Levina, Effect of drug and excipients on release | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2014 Vazquez, Influence of technological variables on release of drugs from hydrophilic matrices | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2015 Joshi WO_2002_087558_A1 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2017 10-30-14 FDA Development and Regulation of Abuse-Deterrent Opioid Medica | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2031 Wright Testimony | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2032 PEO HPMC Paper | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2033 Petition for Inter Partes Review of US Patent No. 9060976 (-1027) | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2005 2015-01-06 IDS | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2006 2015-03-23 References considered | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2007 2016-03-10 NOA 14-728,601 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2008 2016-08-01 NOA 14-733,659 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2009 CPDD Paper 2003 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2012 FDA no generics | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2016 CPDD Paper author biographies | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2019 Attorneys General letter | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2022 Abuse-Deterrent Opioids draft guidance | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2023 HPE Gel forming agents | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2025 US5549912 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2028 Trial testimony 2013 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2029 Oshlak Testimony | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2036 US6696088 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2037 US8652497 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2038 US5266331 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2043 Office Action_10214410 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2046 Oshlack WO_1993_010765_A1 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2048 Sanofi v. Glenmark | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2034 Addendum to 2016-09-23_1.0 Plaintiffs' Opening Claim Construction Brief | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2035 US6228863 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2039 US5656295 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2040 US7141250 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2041 Palmieri Declaration (Kumar)_4520033_2 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2042 Goldberg 60-292,809 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2047 OB Annual - 2001 - 21st Ed | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2049 US6245357 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
2050 USApp20030054027 | Nov 18, 2016 | EXHIBIT | PATENT OWNER |
Joint Motion for Entry of Stipulated Protective Order | Nov 15, 2016 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | Aug 20, 2016 | PAPER | BOARD |
PATENT OWNERS MANDATORY NOTICES PURSUANT TO 37 C.F.R. 48.8(a)(2) | Aug 4, 2016 | PAPER | PATENT OWNER |
IPR2016-01412 Power of Attorney | Aug 4, 2016 | PAPER | PATENT OWNER |
U.S. Patent No. 9,034,376 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Complaint, Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC | Jul 15, 2016 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,337,888 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, No. 2015 1654 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Curriculum Vitae of Anthony Palmieri, Ph.D | Jul 15, 2016 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,508,042 | Jul 15, 2016 | EXHIBIT | PETITIONER |
U.S. 4,070,494 | Jul 15, 2016 | EXHIBIT | PETITIONER |
U.S. Provisional Patent Application No. 60/287,509 | Jul 15, 2016 | EXHIBIT | PETITIONER |
U.S. Patent Publication No. 2002/0187192 | Jul 15, 2016 | EXHIBIT | PETITIONER |
OxyContin, Physicians¿¿¿ Desk Reference 2569 74 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Barry Meier | Jul 15, 2016 | EXHIBIT | PETITIONER |
Brief of Plaintiffs Appellants in Purdue Pharma L.P. et al. v. Amneal | Jul 15, 2016 | EXHIBIT | PETITIONER |
Reply Brief of Plaintiffs Appellants in Purdue Pharma L.P. et al. v. Amneal | Jul 15, 2016 | EXHIBIT | PETITIONER |
Serial No. 13/349,449 | Jul 15, 2016 | EXHIBIT | PETITIONER |
International Publication No. WO 97/49384 | Jul 15, 2016 | EXHIBIT | PETITIONER |
U.S. Provisional Patent Application No. 60/310,534 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Serial No. 14/460,134, Office Action, Oct. 2, 2014 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Complaint, Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC | Jul 15, 2016 | EXHIBIT | PETITIONER |
Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, No. 13 cv 3372 | Jul 15, 2016 | EXHIBIT | PETITIONER |
International Publication No. WO 99/32120 | Jul 15, 2016 | EXHIBIT | PETITIONER |
nternational Publication No. WO 95/20947 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals | Jul 15, 2016 | EXHIBIT | PETITIONER |
Department of Justice, Information Bulletin | Jul 15, 2016 | EXHIBIT | PETITIONER |
Serial No. 10/214,412 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Serial No. 14/460,134, Preliminary Amendment, Aug. 14, 2014 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Serial No. 14/460,134, Notice of Allowance, Mar. 23, 2015 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Oral Dosage Forms, II (94) Remington | Jul 15, 2016 | EXHIBIT | PETITIONER |
Serial No. 14/460,134, Amendment and Response, Jan. 2, 2015 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Serial No. 14/460,134, Request for Continued Examination | Jul 15, 2016 | EXHIBIT | PETITIONER |
CRC Handbook of Chemistry and Physics F-56 (59th ed. 1978) | Jul 15, 2016 | EXHIBIT | PETITIONER |
U.S. 5,273,758 | Jul 15, 2016 | EXHIBIT | PETITIONER |
Serial No. 14/460,134, Second Notice of Allowance | Jul 15, 2016 | EXHIBIT | PETITIONER |
Politics and Government | Jul 15, 2016 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,283,065 | Jul 15, 2016 | EXHIBIT | PETITIONER |
U.S. Patent No.4,861,598 | Jul 15, 2016 | EXHIBIT | PETITIONER |
The Handbook of Pharmaceutical Excipients | Jul 15, 2016 | EXHIBIT | PETITIONER |
Declaration of Dr. Anthony Palmieri | Jul 15, 2016 | EXHIBIT | PETITIONER |
Petition for IPR | Jul 15, 2016 | PAPER | PETITIONER |
Transmittal Letter re Exhibits | Jul 15, 2016 | PAPER | PETITIONER |
Power of Attorney | Jul 15, 2016 | PAPER | PETITIONER |